Caribou Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $387.8M | $240.4M |
| FY2022 | — | $300.9M | $58.3M |
| FY2023 | — | $368.4M | $51.2M |
| FY2024 | — | $253.0M | $16.3M |
| FY2025 | — | $122.2M | $12.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $387.8M | $240.4M |
| FY2022 | — | $300.9M | $58.3M |
| FY2023 | — | $368.4M | $51.2M |
| FY2024 | — | $253.0M | $16.3M |
| FY2025 | — | $122.2M | $12.4M |